IP Library Granted Patent US 8,303,566
Granted Patent B2
US 8,303,566 · App. 12/833,702 · Granted Nov 6, 2012

Methods and apparatus for buffering parenteral solutions

Assignee: Onpharma, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,303,566
App. No.
12/833,702
Granted
Nov 6, 2012
Kind
B2
Abstract

A system for transferring solutions from a first cartridge into a second cartridge comprises a cartridge holder, a plunger driver, and a cartridge connector. The cartridge connector carries a transfer needle and an exhaust needle. The cartridge holder positions the first cartridge against the cartridge connector so that the transfer needle penetrates the first cartridge septum. The second cartridge is removably inserted into another end of the cartridge connector so that both the transfer needle and the exhaust needle penetrate the second cartridge septum. The plunger driver is disposed to advance a plunger on the first cartridge to transfer solution from the first cartridge into the second cartridge thus displacing solution from the second cartridge through the exhaust needle. The cartridge connector includes a sealed interior waste chamber for receiving the solution from the second cartridge.

Claims (34)

1. A method for buffering an anesthetic cartridge, said method comprising:

providing a buffer cartridge having a septum and a plunger;

providing a first anesthetic cartridge having a septum and a plunger;

attaching the buffer cartridge to one end of a cartridge connector so that a first end of a transfer needle penetrates the septum of the buffer cartridge;

attaching the first anesthetic cartridge to another end of the cartridge connector so that a second end of the transfer needle and a first end of an exhaust needle penetrate the septum of the anesthetic cartridge, wherein a second end of said exhaust needle opens to a sealed interior waste chamber in the cartridge connector; and

advancing the plunger on the buffer cartridge to transfer a volume of buffer from the buffer cartridge into the anesthetic cartridge and a volume of anesthetic from the anesthetic cartridge into the sealed interior waste chamber.

2. A method as in claim 1 , further comprising removing the anesthetic cartridge from the cartridge connector after the buffer has been transferred.

3. A method as in claim 2 , further comprising replacing the first anesthetic cartridge with a second anesthetic cartridge on said other end of the cartridge connector and further advancing the plunger to transfer an additional volume of buffer to the second anesthetic cartridge.

4. A method as in claim 3 , wherein additional anesthetic cartridges are sequentially replaced on the cartridge connector and volumes of buffer transferred to said additional anesthetic cartridges until the buffer cartridge is empty.

5. A method as in claim 1 , wherein the cartridge connector is disposed after the buffer cartridge is empty.

6. A method as in claim 1 , further comprising visually observing the buffer cartridge to determine when said buffer cartridge is empty.

7. A method as in claim 1 , wherein the cartridge connector is removably attached to a cartridge holder which holds the buffer.

8. A method as in claim 7 , wherein the cartridge holder has a window that allows visual observation of the contents of the buffer cartridge.

9. A device for transferring a volume of a solution from a first cartridge having a septum to another solution in a second cartridge having a septum, said device comprising:

a cartridge holder having a proximal end, a distal end, and a chamber for removably holding the first cartridge;

a plunger driver attachable to the proximal end of the cartridge holder and having a piston rod which engages a plunger on the first cartridge; and

a cartridge connector having a proximal end attachable to the distal end of the cartridge holder, a distal end adapted to engage a septum end of the second cartridge, and a sealed interior waste chamber, said cartridge connector including a transfer needle and an exhaust needle which extend distally to penetrate the septum end of the second cartridge, wherein the transfer needle extends proximally to penetrate the septum of the first cartridge and the exhaust needle terminates in the sealed interior waste chamber.

10. A device as in claim 9 , wherein the cartridge holder has a cylindrical body with a window to allow visual observation of the contents of a cartridge in the cartridge holder.

11. A device as in claim 10 , wherein a distal region of the cylindrical body is enlarged to removably receive the cartridge connector.

12. A device as in claim 9 , wherein the plunger driver is adjustable so that the length of travel of the piston rod can be selected prior to advancement of said piston rod.

13. A device as in claim 9 , wherein the cartridge connector comprises a cylindrical body that is removably received within the enlarged distal region of the cartridge holder.

14. A device as in claim 13 , wherein the sealed interior waste chamber is defined between spaced-apart wells in the cylindrical body of the cartridge connector.

15. A device as in claim 14 , wherein the first end of the cylindrical body forms a cylindrical sleeve which surrounds the exposed ends of the exhaust needle and the transfer needle, wherein said sleeve is adapted to receive the septum end of a cartridge.

16. A device as in claim 13 , wherein the first end of the transfer needle is axially spaced-apart from the first end of the exhaust needle.

17. A device as in claim 16 , wherein the transfer needle passes axially through the sealed interior waste chamber.

18. A device as in claim 17 , wherein the second end of the transfer needle is free of surrounding structure, said connector further including a removable cap for placing over the exposed second end of the transfer needle.

19. A cartridge connector for providing fluid transfer paths between a first cartridge having a septum and a second cartridge having a septum, said cartridge connector comprising:

a body having a first end, a second end and a sealed interior waste chamber;

a transfer needle having a first end exposed at the first end of the body and a second end exposed at the second end of the body, wherein both the first and second ends of the transfer needle are capable of penetrating a cartridge septum; and

an exhaust needle having a first end exposed at the first end of the body and a second end terminating in the sealed interior waste chamber, wherein the first end of the exhaust needle is capable of penetrating a cartridge septum.

20. A cartridge connector as in claim 19 , wherein the first end includes a cylindrical sleeve surrounding the exposed ends of the transfer needle and the exhaust needle, wherein the sleeve is adapted to receive the septum end of a cartridge.

21. A cartridge connector as in claim 20 , wherein the first end of the transfer needle is axially spaced-apart from the first end of the exhaust needle.

22. A cartridge connector as in claim 21 , wherein the transfer needle passes axially through the sealed interior waste chamber.

23. A cartridge connector as in claim 22 , wherein the second end of the transfer needle is free of surrounding structure, said connector further including a removable cap for placing over the exposed second end of the transfer needle.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2018
From: ONPHARMA INC.
To: ONPHARMA COMPANY
Reel/Frame 046063/0392 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Jul 19, 2017
From: ONPHARMA INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0777 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Dec 3, 2014
From: ONPHARMA INC
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 034524/0018 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2010
From: STEPOVICH, MATTHEW J.; FALKEL, MICHAEL I.
To: ONPHARMA, INC.
Reel/Frame 025037/0735 →
Continuity (2)
Provisional Application 61270571 · Jul 9, 2009
Related Publication 20110166543A1 · Jul 7, 2011